162 related articles for article (PubMed ID: 34830858)
1. Somatostatin Receptors in Human Meningiomas-Clinicopathological Aspects.
Tollefsen SE; Jarmund AH; Ytterhus B; Salvesen Ø; Mjønes P; Torp SH
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830858
[TBL] [Abstract][Full Text] [Related]
2. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.
Silva CB; Ongaratti BR; Trott G; Haag T; Ferreira NP; Leães CG; Pereira-Lima JF; Oliveira Mda C
Int J Clin Exp Pathol; 2015; 8(10):13185-92. PubMed ID: 26722517
[TBL] [Abstract][Full Text] [Related]
3. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin Receptor 2 Expression in Canine Meningioma.
Foiani G; Guelfi G; Chiaradia E; Mancini F; Trivelli C; Vitellozzi G; Lepri E; Mandara MT
J Comp Pathol; 2019 Jan; 166():59-68. PubMed ID: 30691608
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
6. Differences in the expression of SSTR1-5 in meningiomas and its therapeutic potential.
Behling F; Fodi C; Skardelly M; Renovanz M; Castaneda S; Tabatabai G; Honegger J; Tatagiba M; Schittenhelm J
Neurosurg Rev; 2022 Feb; 45(1):467-478. PubMed ID: 33899156
[TBL] [Abstract][Full Text] [Related]
7. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategy.
Zhao WY; Zhuang C; Xu J; Wang M; Zhang ZZ; Tu L; Wang CJ; Ling TL; Cao H; Zhang ZG
Am J Transl Res; 2014; 6(6):831-40. PubMed ID: 25628793
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors.
Vesterinen T; Leijon H; Mustonen H; Remes S; Knuuttila A; Salmenkivi K; Vainio P; Arola J; Haglund C
J Clin Endocrinol Metab; 2019 Jun; 104(6):2083-2093. PubMed ID: 30657933
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
Kumar U
J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.
Lequoy M; Desbois-Mouthon C; Wendum D; Gupta V; Blachon JL; Scatton O; Dumont S; Bonnemaire M; Schmidlin F; Rosmorduc O; Fartoux L
Histopathology; 2017 Feb; 70(3):492-498. PubMed ID: 27391928
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.
Fodi C; Skardelly M; Hempel JM; Hoffmann E; Castaneda S; Tabatabai G; Honegger J; Tatagiba M; Schittenhelm J; Behling F
Neurosurg Rev; 2022 Aug; 45(4):2671-2679. PubMed ID: 34601710
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.
Shimon I
Endocrine; 2003 Apr; 20(3):265-9. PubMed ID: 12721506
[TBL] [Abstract][Full Text] [Related]
15. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic analysis of [
Bashir A; Vestergaard MB; Binderup T; Broholm H; Marner L; Ziebell M; Fugleholm K; Mathiesen T; Kjær A; Law I
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2577-2588. PubMed ID: 32170347
[TBL] [Abstract][Full Text] [Related]
17. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL
World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist.
Dasgupta P; Gűnther T; Schulz S
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
